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A multicomponent hydrogel platform 
that combines oxidative coupling with 
supramolecular coassembly to enable 
tunability of physical, mechanical, and 
biological properties desirable in bone 
tissue regeneration is reported. Specifi-
cally, the strategy permits the integration 
of the osteogenic properties of Laponite 
(Lap), the nanofibrous structure of pep-
tide amphiphiles, the proangiogenic 
properties glycyl-histidyl-lysine peptide, 
and the instant gelation properties of 
tyramine-modified hyaluronic acid. Q4
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FULL PAPER
Growth-Factor Free Multicomponent Nanocomposite 
Hydrogels That Stimulate Bone Formation
Q1 Babatunde O. Okesola, Shilei Ni, Burak Derkus, Carles C. Galeano, Abshar Hasan, 
Yuanhao Wu, Jopeth Ramis, Lee Buttery, Jonathan Dawson, Matteo D’Este,  
Richard OC Oreffo, David Eglin, Hongchen Sun,* and Alvaro Mata*
Synthetic osteo-promoting materials that are able to stimulate and accelerate 
bone formation without the addition of exogenous cells or growth factors will 
represent a major opportunity for an aging world population. a coassembling 
system that integrates hyaluronic acid tyramine (HA-Tyr), bioactive peptide 
amphiphiles (GHK-Cu2+), and Laponite (Lap) is reported to engineer hydrogels 
with physical, mechanical, and biomolecular signals that can be tuned to 
enhance bone regeneration. The central design element of the multicomponent 
hydrogels is the integration of self-assembly and enzyme-mediated oxidative 
coupling to optimize structure and mechanical properties in combination with 
the incorporation of an osteo- and angio-promoting segments to facilitate 
signaling. Spectroscopic techniques are used to confirm the interplay of 
orthogonal covalent and supramolecular interactions in the multicomponent 
hydrogels formation. Electron microscopy and analytical techniques are used to 
confirm coassembly by assessing changes in the nanostructures and elemental 
compositions of the multicomponent hydrogels. Furthermore, physico-
mechanical characterizations reveal that the multicomponent hydrogels 
exhibit improved compressive strength, stress relaxation profile, low swelling 
ratio, and retarded enzymatic degradation compared to the single component 
hydrogels. Applicability is validated in vitro using human mesenchymal stem 
cells and human umbilical vein endothelial cells, and in vivo using a rabbit 
maxillary sinus floor reconstruction model. Animals treated with the HA-Tyr-
HA-Tyr-GHK-Cu2+ hydrogels exhibit significantly enhanced bone formation 
relative to controls including the commercially available Bio-Oss.Q3
DOI: 10.1002/adfm.201906205
1. Introduction
There is an increasing need to develop 
strategies to facilitate bone repair and 
regeneration in and around missing or 
defective craniomaxillofacial regions, 
such as eyes, ears, noses, maxilla, man-
dible, and teeth. One area that requires 
particular attention, given its anatomical 
complexity and potential complications, is 
the posterior maxillary. Here, loss of teeth 
can result in adverse conditions including 
severe maxillary sinus pneumatization, 
which can also increase the risk of root 
tips, teeth displacement into the sinus 
cavity, or microbial contamination of the 
maxillary sinus lift.[1] Therefore, implan-
tation of osseointegrated biomaterials has 
gained widespread attention in dentistry 
to replace missing or lost teeth with suc-
cessful outcomes of complete or partial 
edentulism.[2] However, due to insufficient 
alveolar bone and irregular structure of 
the maxillary sinus in atrophied max-
illa, accidental displacement of a dental 
implant into the maxillary sinus remains 
a common complication encountered in 
dental clinical practice.[3] Consequently, 
maxillary sinus floor reconstruction is 
B. O. Okesola, B. Derkus, C. C. Galeano, A. Mata
Institute of Bioengineering
Queen Mary University of London
London E1 4NS, UK
B. O. Okesola, B. Derkus, C. C. Galeano, A. Mata
School of Engineering and Materials Science
Queen Mary University of London
London E1 4NS, UK
S. Ni
Department of Oral Pathology









A. Hasan, Y. Wu, A. Mata
School of Pharmacy
University of Nottingham
Nottingham NG7 2RD, UK
A. Hasan, Y. Wu, J. Ramis, L. Buttery, A. Mata
Biodiscovery Institute
University of Nottingham
Nottingham NG7 2RD, UK
The ORCID identification number(s) for the author(s) of this article 
can be found under https://doi.org/10.1002/adfm.201906205.

































































































































1906205 (2 of 13) © 2020 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
often necessary. Various bone-grafting biological materials 
including autologous grafts, allogenic bones, and xenografts are 
routinely used in the clinic to aid bone formation for the sinus 
floor.[4,5] Notwithstanding, immunogenicity, donor site mor-
bidity, disease transmission, scarcity of donors, and high cost 
are typically associated with these graft materials.
Significant research efforts have been expended to 
develop effective bone substitutes for maxillary sinus floor 
reconstruction.[6] The majority of the studies have focused on 
the potency of bioceramics including hydroxyapatite, calcium 
phosphate cements,[7] calcium sulfates,[8] bioactive glasses,[9] and 
calcium carbonates[10] given their similarity with the inor-
ganic components of natural bone and the ability of these 
materials to bind to bone and teeth.[11] The success of this 
approach has resulted in a range of popular, commercially 
available, hydroxyapatite powders, cements, and granules 
including: Bio-Oss (Geistlich Ltd., Switzerland) and Fisiograft 
Bone (Ghimas S.p.A, Italy). In addition, hybridization of inor-
ganic materials with polymers and/or growth factors has been 
explored as injectable composite materials for craniomaxillo-
facial bone tissue engineering.[12] Similarly, membranes made 
from synthetic (exe. poly(L-lactic acid) (PLLA), polycaprolactone 
(PCL))[13,14] or natural (exe. collagen, chitosan, alginate)[15,16] 
polymers have been used to promote bone formation as well as 
peptides[17] or proteins[18,19] to selectively stimulate relevant pro-
cesses, such as mineralization. Nonetheless, an ideal bioactive 
scaffold for maxillary sinus floor reconstruction would enable 
the possibility to be delivered through minimally invasive means, 
while rapidly adapting to complex anatomical geometries.[20]
Hydrogels are attractive alternatives to bone grafts given their 
high water content, porosity for oxygen and nutrient perme-
ability, biocompatibility, and responsiveness to environmental 
stimuli. Tailored-made hydrogels enable the incorporation of 
specific bioactive epitopes[21] and exhibit physical properties, 
such as non-Newtonian behavior to facilitate injectability.[22] 
However, the use of injectable hydrogels in maxillofacial surgery 
is limited and in most cases hydrogels have been used mainly 
as a delivery vehicle for growth factors, such as bone morphoge-
netic protein-2 (BMP-2) and vascular endothelial growth factor 
(VEGF).[23–25] Furthermore, while growth factors are efficient 
promoters of tissue growth, their use is associated with a variety 
of critical complications, such as the need for large amounts of 
growth factors due to the rapid inactivation and clearance of the 
growth factors,[26] high-costs, and uncontrolled activity.[27]
Thus, an ideal therapeutic hydrogel for maxillary sinus lift 
reconstruction/augmentation should also be biodegradable 
generating nontoxic products, be simple to implant, exhibit 
a short set time, be mechanically stable, and rapidly fill irreg-
ular anatomical volumes.[28] Furthermore, given the complex 
anatomy and physiology of bone, the hydrogel should hold 
multifunctional properties to recreate key features of the extra-
cellular matrix (ECM) and stimulate cell types of interest. In 
this context, multicomponent self-assembly offers an attractive 
avenue to design hydrogels with multiple building-blocks, func-
tionalities, and the molecular precision of self-assembly.[29,30]
In this study, we have developed a three-component self-
assembling system that integrates hyaluronic acid (HA), pep-
tide amphiphiles (PAs), and Laponite (Lap). HA is a large ECM 
polysaccharide ubiquitous in tissues and organs that has been 
extensively used as a biomaterial due to its biocompatibility 
and biodegradability.[31] However, HA exhibits poor structural 
integrity and stability and consequently is usually chemically 
modified with, for example, tyramine (Tyr)[32] or hybridized 
with other biomaterials, such as hydroxyapatite[33] to increase 
its functionality. PAs are a class of self-assembling peptide-
based building blocks with the intrinsic capacity to assemble 
into well-defined nanofibrous hydrogels.[34] PAs consist of: i) a 
hydrophobic tail that drives self-assembly, ii) a β-sheet forming 
amino acid sequence that stabilizes the assembled nanofibers 
through hydrogen bonds, and iii) a charged functional head 
group that facilitates solubility in aqueous environments. This 
platform can incorporate a spectrum of bioactive epitopes, 
which have been used to target regeneration of tissues, such 
as bone,[35] enamel,[36] cartilage,[37] and vascular.[38] However, 
self-assembling materials typically provide limited structural 
integrity, which has hindered their wide spread applicability. 
Lap is a 2D nanosilicate with anisotropic charge distribution, 
which has been exploited as an effective cross-linker and rhe-
ology modifier for hydrogels[39] for the delivery of drugs, growth 
factors, and antibodies.[40,41] Lap has been reported to promote 
cell adhesion and proliferation and can exert osteogenic effects 
on cells in vitro.[42] Consequently, Lap has been combined with 
macromolecules, such as DNA[43] or proteins[44] to fabricate 
hydrogels capable of promoting osteogenic differentiation in 
vitro[45,46] or bone regeneration in vivo in mice.[44]
Here, we report the synthesis and characterization of a 
multicomponent self-assembling system that integrates the 
osteogenic properties of Lap, the signaling and nano fibrous 
structure of PAs, the proangiogenic properties of the GHK-Cu2+ 
peptide, and the biocompatibility and instant gelation prop-
erties of Tyr-modified HA to fabricate an osteoinductive and 
osteoconductive hydrogel for bone regeneration. The system 
also takes advantage of both covalent (oxidative coupling) and 
noncovalent (electrostatic) interactions to generate a mate-
rial that is both injectable and robust. The applicability of the 
materials was assessed in vitro using human mesenchymal 
stem cells (hMSCs) and human umbilical vein endothelial 
cells (hUVECs), and in vivo using a rabbit maxillary sinus floor 
reconstruction model.
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2. Results and Discussion
2.1. Rationale of Design
Our approach enables the rationale design of complex and mul-
tifunctional hydrogels for bone regeneration (Figure 1a–d). We 
used HA to provide a rich and biocompatible ECM macromol-
ecule, which was functionalized with Tyr (HA-Tyr) to control 
stability through enzyme-mediated oxidative coupling as previ-
ously described by Eglin and co-workers.[47] To further enhance 
the hydrogel’s structural integrity and bioactivity, we designed 
PA molecules to coassemble with HA-Tyr through electrostatic 
interactions into nanofibers that exhibit the proangiogenic oste-
onectin fragment glycine-histidine-lysine (GHK-Cu2+).[48] In 
addition, Laponite discs (Lap) were incorporated to provide a 
distinctive dual-charged structure (i.e., positive rim and nega-
tive face charge of the nanaosilicate disc) that would facilitate 
interaction with both the anionic charged HA-Tyr and the 
cationic PA (GHK-Cu2+). It is noteworthy that the osteogenic 
effects of Lap can be an additional benefit. Finally, to facilitate 
temporal control of assembly and implantation, the hydrogels 
were designed to assemble instantly through; a) oxidative cou-
pling of the phenolic moiety of HA-Tyr mediated by horseradish 
peroxidase and H2O2, which has been demonstrated to be bio-
compatible both in vitro and in vivo,[49] as well as b) electrostatic 
interactions between the cationic GHK-Cu2+, anionic HA-Tyr, 
and anionic/cationic Lap.
2.2. Synthesis and Characterization of the GHK-Cu2+ PA
The PA molecule (GHK-Cu2+) used in this study is a three-
domain molecule with a hydrophobic tail (black), β-sheet 
forming amino acid residues (blue), and the therapeutic cati-
onic tripeptide matrikine (pink) derived from osteonectin 
(C16H31CO-VVVAAAGHK) (Figure 1b). In order to present 
GHK as a complex of copper (the form in which it exists in the 
human body), we mixed an aqueous solution of copper (II) sul-
fate (CuSO4. 5H2O) (4 mg mL−1) with a GHK solution (2 wt%). 
The copper chelating ability (GHK-Cu2+) was confirmed by elec-
tron paramagnetic resonance (EPR) spectroscopy (Figure S1, 
Supporting Information). The circular dichroism (CD) spec-
trum of GHK-Cu2+ demonstrated a β-sheet-like bisignate 
with a maximum and minimum at 198 and 220 nm, respec-
tively (Figure S2, Supporting Information), while transmission 
electron microscopy (TEM) confirmed self-assembly into the 
classical PA nanofibrous morphology measuring ≈10 nm in 
diameter and several microns in length (Figure S3, Supporting 
Information).
2.3. Synthesis and Characterization of the Hydrogels
The multicomponent system (HA-Tyr-Lap-GHK-Cu2+) was 
prepared in stages. First, a HA-Tyr solution (6 wt%) in horse-
radish peroxidase (HRP)-containing phosphate buffer saline 
Adv. Funct. Mater. 2020, 1906205
Figure 1. a) Structural formula for hyaluronic acid tyramine (HA-Tyr), b) Structural formula for peptide amphiphile (GHK), c) Structural representation 
of Laponite (Lap) discs. d) Schematic representation of multicomponent coassembly of HA-Tyr-Lap mixtures and GHK-Cu2+ to fabricate nanocomposite 
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(PBS) was combined with exfoliated Lap (5 wt%). Separately, 
an aqueous solution of GHK-Cu2+ (2 wt%) was combined with 
H2O2 (0.75 × 10−6 M). Upon mixing both solutions, instant 
gelation occurred by HRP mediated oxidative coupling of the 
phenolic moiety on HA-Tyr using H2O2 as oxidant and by elec-
trostatic interactions between the GHK-Cu2+ with both Lap and 
HA-Tyr. The hydrogels HA-Tyr, HA-Tyr-GHK-Cu2+, and HA-Tyr-
Lap were prepared as described in the Experimental Section 
and used as controls. In all cases, self-supported and robust 
hydrogels were formed (Figure S4, Supporting Information). 
Due to the multicomponent nature of the hydrogels, these 
were prepared with fixed concentrations of both HA-Tyr[50] and 
Lap[45] that have been previously reported by others to exhibit 
suitable mechanical properties and bioactivity. We used fluo-
rescence and attenuated total reflectance-Fourier transform 
infrared (ATR-FTIR) spectroscopies to investigate molecular 
interactions underpinning coassembly of the various compo-
nents in our hydrogels. The fluorescence emission spectra of 
HA-Tyr solution and hydrogels prepared by oxidative coupling 
were examined. Spectra were collected at an excitation wave-
length (λex) of 260 nm. The fluorescence spectra from HA-Tyr 
solution (0.5 wt%) depicted a weak broad emission maxima 
(λem) at 330 nm, which corresponds to the emission wavelength 
of a phenolic group (Figure S5, Supporting Information). Upon 
oxidative coupling the spectra shows an intense emission 
maxima at 422 nm with a shoulder at 450 nm (Figure S5, Sup-
porting Information). The redshifted fluorescence emission is 
indicative of peroxidase-catalyzed oxidative coupling leading to 
dityramine/dityrosine bridge formation.[51]
The FTIR spectrum of GHK exhibited a band at 3250 cm−1 
due to N–H vibrational stretching of amide II, 2952 and 
2850 cm−1 due to C–H stretching of alkyl groups, 1632 cm−1 
due to CO stretching of amide I, 1540 cm−1 due to N–H 
stretching of amide II (aromatic) and 1230 cm−1 due to N–H 
stretching of amide III (Figure S6, Supporting Information). 
For HA-Tyr xerogel, the characteristic absorption bands were 
observed at 3200, 1638, 1540, and 1020 cm−1 corresponding 
to the O–H vibrational stretching, CO stretching of amide I, 
N–H stretching of amide II, and C–O asymmetric vibrational 
stretching, respectively (Figure S6, Supporting Information). 
The distinctive absorption band at 993cm−1 in the spectrum of 
Lap was attributed to the Si–O vibrational stretching.[45] In the 
spectrum of HA-Tyr-GHK-Cu2+ xerogel, we observed a slight 
shift in the vibrational stretching frequency of the CO region 
to 1635 cm−1, suggesting hydrogen bond with associated 
electrostatic interactions between HA-Tyr and GHK-Cu2+. Sim-
ilarly, the spectrum of HA-Tyr-Lap xerogel shows that the CO 
and Si–O bands shifted to 1635 and 1000 cm−1, respectively, 
which is indicative of hydrogen bond interactions between 
HA-Tyr and Lap. Interestingly, all the changes observed in the 
chemical environments of the functional groups (see HA-Tyr-
GHK and HA-Tyr-Lap) were also revealed in the spectrum of 
the multicomponent HA-Tyr-Lap-GHK-Cu2+ xerogels. Given 
the evidence of the peroxidase-mediated oxidative coupling of 
HA-Tyr and the electrostatic and hydrogen bond interactions 
provided by Lap and the cationic GHK-Cu2+, we reasoned that 
the synthesis of our multicomponent HA-Tyr-Lap-GHK-Cu2+ 
hydrogels is based on orthogonal interactions between all the 
components.
2.4. Structural Properties of the Hydrogels
Scanning electron microscopy (SEM) observations revealed 
that the GHK-Cu2+ hydrogel exhibited the classical PA nano-
fibrous architecture[34] (Figure 2a), while the HA-Tyr hydrogel 
exhibited a microporous morphology (Figure 2b) as previously 
described.[52] As expected, HA-Tyr-GHK-Cu2+ hydrogels exhib-
ited features of both of these hydrogels including nanofibers 
and microscopic pores (Figure 2c). The multicomponent 
HA-Tyr-Lap-GHK-Cu2+ hydrogels revealed an architecture that 
combined and retained all these features (Figure 2e) with Lap 
uniformly distributed on the surface of the fibers (Figure 2f), as 
evidenced by energy dispersive X-ray (EDX) analysis confirming 
the presence of Si, Mg, Na, and O (Figure 2g). Although SEM 
examinations are not the ideal approach to describe in detail 
the structure of each hydrogel given the likelihood for structure 
disruption as a result of the sample preparation, the results 
provide a useful relative comparison between the different 
hydrogels.
2.5. Mechanical and Physical Properties of the Hydrogels
A major goal of our design was to provide a multifunctional 
bioactive hydrogel that could stimulate specific biological 
processes while being a robust and easy to use system. To test 
the structural and mechanical properties of the hydrogels, 
we performed a number of tests including compressive tests, 
stress relaxation measurements, swelling tests, and enzymatic 
degradation experiments.
Compression tests were performed on 5 mm diameter and 
5 mm high cylindrical hydrogels. HA-Tyr hydrogels exhibited 
a Young’s modulus of 25.03 ±  4.00 (Figure 2h; and Figure S7, 
Supporting Information), in agreement with those of previous 
studies.[50] Interestingly, upon co-assembly with GHK-Cu2+ 
the Young’s modulus of the hydrogel increased slightly up to 
28.18 ±  4.32 kPa (HA-Tyr-GHK-Cu2+), which may result from 
an enhanced entanglement with the PA nanofibers and conse-
quent slight decrease in porosity (Figure 2c). Importantly, upon 
coassembly with Lap, the hydrogels exhibited a significantly 
increase in Young’s moduli up to 58.23 ±  7.8 kPa (HA-Tyr-
Lap) and 63.11 ±  8.0 kPa (HA-Tyr-Lap-GHK-Cu2+) (Figure 2h, 
Figure S7, Supporting Information), indicating that the dit-
yramine moieties (HATyrTyrHA bonds) that result from 
enzymatic crosslinking of the tyramine form strong physical 
interfacial bonds with Lap. These results are in agreement with 
previous studies that have reported a Lap-induced increase in 
the stiffness of hydrogels[53] and evidence the potential of our 
hydrogels to be used as robust and bioactive hydrogel implants 
for bone regeneration.
It is well-established that hydrogel stiffness plays a cru-
cial role in directing cell phenotype and that stiffer hydrogels 
(>30 kPa) are able to promote osteoblastic phenotypes.[54] While 
the Young’s modulus of our multicomponent HA-Tyr-Lap- 
GHK-Cu2+ hydrogel is higher (63.11 kPa), differences in stiff-
ness measuring techniques and other hydrogel properties such 
as porosity and stress relaxation are important to consider. In 
addition to the effect of hydrogel stiffness on cell behavior, stress 
relaxation has also been shown to play a role in cell signaling 
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by modulating ligand binding and cytoskeletal organization.[55] 
Stress relaxation tests revealed that all multicomponent hydro-
gels and HA-Tyr exhibited a similar relaxation profile of ≈55% at 
about 5 min (Figure 2i). This behavior is likely due to reversible 
transient molecular interactions and reorganization of the HA 
chains and/or PA nanofibers as well as release of entangle-
ments driven by in situ formation of dityrosine bridges between 
adjacent tyramine moieties in the HA-Tyr chains. However, in 
Adv. Funct. Mater. 2020, 1906205
Figure 2. SEM micrographs of dried xerogels of a) GHK-Cu2+, b) HA-Tyr, c) HA-GHK- Cu2+, d) HA-Tyr-Lap, e) HA-Tyr-Lap-GHK-Cu2+, and f) close 
image of HA-Tyr- Lap-GHK-Cu2+ revealing Lap nanoparticles. g) EDX elemental analysis of dried xerogels of HA-Tyr-Lap-GHK-Cu2+. h) Young’s 
moduli for HA-Tyr, HA-Tyr-GHK-Cu2+, HA-Tyr-Lap, and HA-Tyr-Lap-GHK-Cu2+ hydrogels. i) Stress relaxation profiles for HA-Tyr, HA- Tyr-GHK-Cu2+, 
HA-Tyr-Lap, and HA-Tyr-Lap-GHK-Cu2+ hydrogels. j) Swelling ratio of HA-Tyr, HA-Tyr-GHK-Cu2+, HA-Tyr-Lap, and HA-Tyr-Lap-GHK-Cu2+ hydrogels. 
k) Enzymatic degradation profiles for HA-Tyr, HA-Tyr-GHK-Cu2+, HA-Tyr-Lap, and HA-Tyr-Lap-GHK-Cu2+ hydrogels. A fixed concentration (2 wt%) of 
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the initial the 10 s, HA-Tyr-Lap-GHK-Cu2+ hydrogels exhibit 
a faster relaxation profile compared to all other hydrogels 
(Figure 2i). This rapid hydrogel stress relaxation has been 
shown to promote proliferation and differentiation toward an 
osteoblastic phenotype of mesenchymal stem cells (MSCs).[55] 
These results demonstrate that the multicomponent covalent 
and noncovalent approach also generates a hydrogel relaxation 
profile with potential benefit for bone regeneration applications.
The propensity of hydrogels to absorb and retain water pro-
vides a measure of structural integrity and adaptability as well 
as capacity to enable critical nutrient and waste diffusion. Con-
sequently, we conducted swelling experiments on freeze-dried 
hydrogels by immersing them in PBS and systematically cal-
culating the percentage of water uptake at 0, 10, 20, 30, and 
40 min. HA-Tyr hydrogels exhibited an exceptionally high 
swelling ratio of 1680 ±  94% after 10 min of immersion in PBS, 
which increased to 1840 ±  87% after 40 min (Figure 2j). Simi-
larly, HA-Tyr-GHK-Cu2+ hydrogels displayed a high swelling 
ratio of 1540 ±  57% which increased to 1802 ±  51%, after 
40 min. In contrast, Lap-containing hydrogels exhibited lower 
swelling ratios of 1470 ±  45% (HA-Tyr-Lap) and 1350 ±  17% 
(HA-Tyr-Lap-GHK-Cu2+) after 10 min of incubation, which 
increased to 1540 ±  35% (HA-Tyr-Lap) and 1580 ±  24% 
(HA-Tyr-Lap-GHK-Cu2+) after 40 min (Figure 2j). This decrease 
suggests that despite the ionic and hydrophilic nature of Lap, 
its presence impedes water uptake. Since the degree of swelling 
ratio is inversely proportional to the crosslinking density of 
hydrogels,[56] we reasoned that both the physical crosslinking 
provided by the Lap discs and covalent crosslinking between 
the tyramine moieties (HATyrTyrHA bonds) significantly 
limit water uptake in HA-Tyr-Lap and HA-Tyr-Lap-GHK-Cu2+ 
hydrogels. Nonetheless, all hydrogels exhibited a relatively fast 
and high level of equilibrium swelling ratio, returning to their 
original size upon rehydration (Figure 2j). This capacity may 
facilitate their use as geometrically customized hydrogels that 
can be dried, stored, and rehydrated prior to implantation.
Controlled degradation is another important parameter for 
bioactive implantable hydrogels aiming to balance stimulation of 
cell growth and adequate replacement of new tissue. While HA 
has been extensively pursued as a biomaterial, its use to fabricate 
robust scaffolds for tissue regeneration has been limited in large 
part by its susceptibility to rapid degradation in the presence of hya-
luronidases both in vitro and in vivo.[57] Several approaches have 
been devised to enhance HA hydrogel stability to enzymatic deg-
radation with varying degree of success.[58,59] Our design enables 
the possibility to combine covalent and noncovalent interactions 
as well as exploit synergistic interactions between the different 
components. To test this, hydrogels were prepared, immersed in 
aqueous solutions of hyaluronidase (20 U mL−1) at 37 °C, and their 
weight measured at various times points up to 50 d (Figure 2k). 
At 18 d, HA-Tyr hydrogels were found to be completely digested, 
while the multicomponent (HA-Tyr-GHK-Cu2+, HA-Tyr-Lap, 
and HA-Tyr-Lap-GHK-Cu2+) hydrogels resisted full degrada-
tion up to 50 d (Figure 2k). In particular, Lap-containing hydro-
gels exhibited a significant decrease in degradation rate, which 
correlates with previous studies also reporting an enhanced Lap-
induced stability in polymers[60] and biopolymers.[45] We speculate 
that the suppressed hydrogel susceptibility to rapid enzymatic 
degradation observed in HA-Tyr-Lap and HA-Tyr-Lap-GHK-Cu2+ 
may be attributed to the strong affinity of Lap discs to proteins 
and enzymes through physical adsorption,[41] which would conse-
quently limit hyaluronidase access to the HA backbone.
2.6. In Vitro Assessment of the Hydrogels
2.6.1. Viability and Proliferation of hMSCs
To test the applicability of the multicomponent hydrogels, 
we first conducted in vitro tests by culturing hMSCs on the 
materials. Using a live/dead assay, cytocompatibility was 
first assessed. As expected, HA-Tyr alone did not support cell 
attachment and spreading (Figure 3), likely as a result of lack 
of cell-binding motifs.[52] However, cells cultured on all multi-
component HA-Tyr-GHK-Cu2+, HA-Tyr-Lap, and HA-Tyr-Lap-
GHK-Cu2+ hydrogels adhered and appeared to exhibit a spread 
Adv. Funct. Mater. 2020, 1906205
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morphology (Figure 3b–d) on days 1, 3, and 7 similar to cells 
cultured on tissue culture plastic (TCP) (Figure 3e). We then 
examined the effect of the hydrogels on hMSC proliferation and 
found that cell number increased from day 1 to 7 on all mul-
ticomponent hydrogels, with greater increase on HA-Tyr-Lap-
GHK-Cu2+ compared to HA-Tyr-Lap and HA-Tyr-GHK-Cu2+. 
In addition, cell proliferation was higher on HA-Tyr-Lap-GHK-
Cu2+ prepared with the higher concentration of GHK-Cu2+ 
(1 wt%) compared to the lower one (0.1 wt%) (Figure 4a), which 
is in agreement with previous work reporting the stimulating 
role of GHK on cell proliferation.[61]
2.6.2. Osteoblastic Differentiation of hMSCs
Next, we assessed the osteoinductive potential of the multi-
component hydrogels by growing hMSCs using culture media 
with and without osteoinductive agents and quantifying alka-
line phosphatase (ALP) expression. In this case, we tested 
three different hydrogels comprising different concentrations 
of GHK-Cu2+. In osteoinductive media, up-regulation of ALP 
activity was observed on all hydrogels with highest expression 
at day 4 on the TCP control compared to day 9 for the multi-
component hydrogels, suggesting a delayed expression on the 
hydrogels (Figure S9, Supporting Information). However, in 
the absence of osteoinductive media, a more indicative scenario 
of the inductive properties of the materials, ALP expression 
peaked for all tested substrates on day 9. In this case, the 
highest expression was observed on the HA-Tyr-Lap-GHK-Cu2+ 
hydrogels containing the highest concentration of GHK-Cu2+ 
compared to all other hydrogels and TCP control (Figure 4b). 
This result suggests that the multicomponent HA-Tyr-Lap-
GHK-Cu2+ hydrogel has the capacity to stimulate osteoblastic 
differentiation on hMSCs in the absence of osteoinductive 
Adv. Funct. Mater. 2020, 1906205
Figure 4. a) Quantitative measurement of cell proliferation on HA-Tyr, HA-Tyr-GHK-Cu2+, HA-Tyr-Lap, HA-Tyr-Lap-GHK-Cu2+ hydrogels, and TCP. 
b) Osteogenic differentiation of hMSCs without osteoinductive media on HA-Tyr, HA-Tyr-GHK-Cu2+, HA-Tyr-Lap, HA-Tyr-Lap-GHK-Cu2+ hydrogels, 
and TCP (*, **, ***, **** indicate significant difference with respect to the color code, p = 0.01–0.001, p < 0.001, p = 0.001–0.0001, and p < 0.0001, 
respectively). c) CLSM images of calcein-stained hUVECs at day 1 on (i) HA-Tyr, (ii) HA-Tyr-Lap, (iii) HA-Tyr-GHK-Cu2+, and (iv) HA-Tyr-Lap-GHK-Cu2+ 
hydrogels and day 5 on (v) HA-Tyr, (vi) HA-Tyr-Lap, (vii) HA-Tyr-GHK-Cu2+ (inset: large lumen), (viii) HA-Tyr-Lap-GHK-Cu2+ hydrogels, (ix) Matrigel-

































































































































1906205 (8 of 13) © 2020 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
factors. Furthermore, the dose-dependent effect of GHK-Cu2+ 
on ALP activity is in agreement with previous reports on the 
osteogenic effect of copper-free alginate-GHK hydrogels.[61]
2.6.3. Angiogenic Effect on hUVECs
Blood vessel formation is essential in bone regeneration. 
Therefore, we qualitatively assessed the in vitro proangio-
genic effect of the multicomponent hydrogels on hUVECs. 
By comparing the morphology of calcein-stained hUVECs 
growing on the different materials, GHK-Cu2+-containing 
multicomponent hydrogels HA-Tyr-GHK-Cu2+ and HA-Tyr-
Lap-GHK-Cu2+ were observed to trigger cell elongation and 
angiogenic sprouting with microcapillary-like structures by 
day 1 of culture (Figure 4c_(iii–iv)). In contrast, cells seeded 
on HA-Tyr and HA-Tyr-Lap (without GHK-Cu2+) maintained 
their normal endothelial phenotype (Figure 4c_(i–ii). In addi-
tion, a more complex vascular lumen[62] structure was also 
formed on the GHK-Cu2+-containing hydrogels after day 5 
(Figure 4c_(vii–viii)). Such lumen structures were similar to 
those observed on the positive control (Matrigel + 50 ng mL−1 
VEGF) (Figure 4c_(ix)) at day 5. These results suggest that the 
GHK-Cu2+-containing multicomponent hydrogels have proan-
giogenic properties.
The proangiogenic effects and ability of GHK to increase 
VEGF secretion have been previously associated with its 
binding to α6 or β1 integrin or both.[63] Also, a recent metabo-
lomics pathway analysis of cells in alginate-GHK hydrogels 
revealed that the integrin linked kinase mediates the numerous 
biological functions of GHK tripeptide.[61] The formation of 
vascular system is mainly ensured by the emergence of new 
microcapillary from existing vessels (sprouting).[64]
2.7. In Vivo Assessment of the Hydrogels
To test the bioactivity and in vivo bone regenerative capacity 
of the hydrogels, experiments were conducted on a standard 
sinus rabbit model following established protocols.[65] The 
four hydrogel materials were tested with untreated animals 
serving as negative controls and animals treated with the 
commercial product Bio-Oss (Geistlich Ltd., Switzerland) 
as positive controls. Bio-Oss is a bone substitute material 
derived from deproteinized bovine bone marrow and has 
been widely used in regenerative dentistry with good suc-
cess as a filler for maxillary sinus augmentation.[6] Animals 
were implanted with 50 µL of the hydrogels or positive con-
trol, sacrificed at either 6 or 12 weeks after implantation, and 
assessed qualitatively and quantitatively for bone formation 
and cytotoxicity.
All animals survived surgery and exhibited normal behavior 
during the implantation time and no signs of inflammation 
or infection were physically observed at the time of sacrifice. 
Cone beam computer tomography (CBCT) was used to quali-
tatively assess differences in the performance of the different 
materials. At 6 and 12 weeks, CBCT scans revealed new bone 
formation in the sinus of animals treated with the hydrogels 
and positive control (Bio-Oss) (Figure 5b). However, higher 
contrast likely associated with new bone formation was 
observed in animals treated with the multicomponent hydro-
gels, especially those treated with the HA-Tyr-Lap-GHK-Cu2+ 
hydrogels. Interestingly, this enhancement also appeared to be 
larger than animals treated with the positive control at both 6 
and 12 weeks’ time-points. It is noteworthy that the radiation 
resistant area in the sinus of the positive control is partly due 
to the residual materials of the Bio-oss, which can be difficult 
to distinguish from the newly mineralized tissue. Nonethe-
less, the results suggest that the HA-Tyr-Lap-GHK-Cu2+ hydro-
gels are capable of promoting new bone formation within the 
sinus.
To confirm this result, histological sections stained with 
hematoxylin and eosin (HE) were acquired from animals at 
6 and 12 weeks after implantation. Animals implanted with 
the HA-Tyr-Lap-GHK-Cu2+ hydrogels qualitatively exhibited 
greater amounts of newly formed bone compared to animals 
treated with all other hydrogels and controls at both weeks 6 
and 12, evidenced by the presence of relevant cells and ossi-
fied tissue (Figure 5c). These histological sections were then 
used to quantify new bone formation within the sinus region 
by identifying and quantifying the areas within the sinus 
region exhibiting osteocytes and ossified tissue (Figure 5a). At 
both 6 and 12 weeks postsurgery, the results confirmed that 
animals receiving the multicomponent HA-Tyr-Lap-GHK-
Cu2+ hydrogels revealed the highest percentage of mean area 
of ossified tissue (40.37 ±  1.54 and 60.12 ±  2.80%, respec-
tively) within the sinus of all tested groups including signifi-
cantly higher than animals treated with the positive control 
(35.97 ±  1.54% and 37.56 ±  1.18%, respectively) (Figure 6a). 
The histological sections of animals treated with the HA-
Tyr-Lap-GHK-Cu2+ hydrogels also exhibited both osteoblasts 
and osteocytes within lacuna, further evidencing the pres-
ence of an active regenerative environment (Figure 6b). It is 
likely that these cells emerged from MSCs or preosteoblasts 
migrating from the local bone surface, periosteum, or the 
blood. By comparing these results with those of the other 
hydrogels (Figure 6a), we conclude that the enhanced bioac-
tivity of HA-Tyr-Lap-GHK-Cu2+ hydrogels may result primarily 
from the presence of Lap and GHK-Cu2+. These results cor-
relate with the in vitro results, which show that Lap and espe-
cially GHK may have osteoinductive properties in the absence 
of growth factors. Vascularization is of upmost importance 
in bone regeneration. Closer examination of the histological 
sections revealed that animals treated with HA-Tyr-Lap-GHK-
Cu2+ exhibited a qualitatively higher amount of blood vessels 
compared to animals treated with HA-Tyr-GHK-Cu2+ and the 
positive control (Figure 6c). Interestingly, blood vessels were 
much less prevalent in hydrogels that did not contain GHK-
Cu2+, which is in accordance with the in vitro experiments as 
well as previous studies that have reported on the ability of 
GHK-Cu2+ to promote formation of blood vessels in mice.[66] 
The in vivo experiments were also used to investigate the 
biosafety of the hydrogels through a systemic toxicity test. His-
tological sections of the liver, heart, spleen, lung, and kidney 
from the animals treated with the HA-Tyr, HA-Tyr-GHK-Cu2+, 
HA-Tyr-Lap, and HA-Tyr-Lap- GHK-Cu2+ hydrogels were exam-
ined and presented no signs of inflammation or histological 
changes compared to control animals (Figure S11, Supporting 

































































































































1906205 (9 of 13) © 2020 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
Information). These results suggest that the HA-Tyr-Lap-GHK- 
Cu2+ hydrogels did not degrade into toxic by-products. We 
speculate that, beyond the molecular signaling and biocompati-
bility of the HA-Tyr-Lap-GHK-Cu2+ hydrogel, its high osteo-pro-
moting activity may also result from the inherent mechanical 
and physical properties of the hydrogel. Both the hydrogel’s 
Young’s modulus (Figure 2h) and stress relaxation profile 
(Figure 2i) exhibit values that have been reported to be ben-
eficial for bone promoting applications.[54,55] Furthermore, the 
hydrogels display an enzymatic degradation profile (Figure 2k) 
that may have permitted sufficient signaling to migrating and 
surrounding cells while progressively degrading to enable new 
tissue formation. This capacity for timely scaffold degrada-
tion is key for optimum tissue regeneration.[67] Furthermore, 
beyond these beneficial molecular, chemical, and physical 
properties, the potential to easily manipulate and deliver the 
hydrogel represent key advantages to facilitate its clinical use 
and impact.
3. Conclusion
We have developed a practical and multifunctional self-assem-
bling hydrogel biomaterial for bone regeneration applications. 
The material takes advantage of both covalent and noncova-
lent interactions to integrate HA, PAs, and Lap into a bioactive 
hydrogel with a spectrum of molecular, physical, and mechan-
ical properties designed to promote bone regeneration as 
well as minimally invasive implantation. We demonstrate the 
capacity of the hydrogels to support cell growth and stimulate 
both osteoblastic differentiation and angiogenic sprouting of 
hUVECs in vitro as well as promote faster bone regeneration 
in a rabbit model compared to a commercially available gold-
standard material. The current study introduces a new molecu-
larly designed self-assembling material that stimulates bone 
formation without the use of exogenous growth factors and 
demonstrated its potential use in maxillary sinus reconstruc-
tion and other bone tissue regeneration procedures.
Adv. Funct. Mater. 2020, 1906205
Figure 5. a) Schematic representation of new bone area in the maxillary sinus. b) Cone beam computed tomography (CBCT) scan results of sinus 
floor treated with HA-Tyr, HA-Tyr-GHK-Cu2+, HA-Tyr-Lap, and HA-Tyr-Lap-GHK-Cu2+ hydrogels compared with sinus treated with nothing and those 
treated with Bio-Oss after 6 and 12 weeks postsurgery. c) New bone formation detected by hematoxylin and eosin (HE) staining shows local histological 
images of the different groups at 6 and 12 weeks postsurgery, respectively. The black, blue, and orange arrows indicate the new trabecular bone and 
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4. Experimental Section
Materials: Laponite XG was a generous gift from the laboratory of 
Professor Richard OC Oreffo and Dr. Jonathan Dawson, University of 
Southampton while HA-Tyr was synthesized as previously described 
elsewhere.[45] Dulbecco’s Modified Eagle’s Medium (DMEM), fetal 
bovine serum (FBS), PBS, penicillin, and streptomycin, horseradish 
peroxidase, hydrogen peroxide were purchased from sigma-Aldrich Inc. 
(UK). The Live/Dead assay kits (calcein AM and ethidium homodimer) 
were purchased from Thermo Fisher Scientific Ltd (UK).
Peptide Synthesis and Characterization: PAs were synthesized 
as previously described[68] by solid phase peptide synthesis on 
Liberty Blue-automated microwave peptide synthesizer (CEM Ltd, 
UK). The standard 9-fluorenylmethoxycarbonyl (Fmoc) protection 
chemistry on a 4-methylbenzhydrylamine (MBHA) Rink Amide 
resin (Novabiochem Corporation, UK) was employed. Amino acid 
couplings were performed using 4 mmol equivalent of Fmoc-protected 
amino acids (Novabiochem Corporation, UK), 4 mmol equivalents 
of 1-hydroxybenzotriazol (HOBT, Carbosynth Ltd, UK) and 6 mmol 
equivalents of N,N’-diisopropylcarbodiimide (DIC, Sigma-Aldrich Inc., 
UK) for 1 h. Fmoc deprotections were performed with 20% piperidine 
(Sigma-Aldrich Inc., UK) in N,N-dimethylformamide (DMF, Alfa Aesar 
Inc., UK). Following Fmoc removal from the final amino acid residue, 
the alkyl tail moiety (from palmitic acid, C16H32O2, Calbiochem Inc., 
UK) was conjugated to the free N-terminus. The alkylation reaction 
was accomplished by using palmitic acid (4 mmol), HOBT (4 mmol), 
and DIC (6 mmol) in DMF/dichloromethane. The reaction was 
allowed to proceed at room temperature for 4 h or until obtaining a 
negative Kaiser test. PA cleavage from the resin and deprotection of 
the side chains were carried out with a mixture of trifluoracetic acid 
(TFA, Sigma-Aldrich Inc., UK)/triisopropylsilane (TIS, Alfa Aesar Inc., 
UK)/water (95:2.5:2.5) for 3 h at room temperature. After filtration of 
the cleavage mixture, TFA was removed by rota-evaporation and the 
resulting solution was triturated with cold diethylether at −20 °C. The 
precipitate was collected by centrifugation, washed twice with cold 
diethylether, air-dried, dissolve in deionised water and lyophilized. 
The product was then purified using a preparative HPLC (Waters Ltd, 
USA) with reverse-phase Xbridge C18 column (Waters Ltd, USA) and 
water/acetonitrile (0.1% TFA) binary mobile phase. Hydrochloric acid 
(10 × 10−3 M) was added to the HPLC fractions and rotavap to remove 
the residual TFA, leaving behind chloride as the PA counter ions. 
Finally, the PA was dialyzed against deionized water using 500 MWCO 
dialysis tubing (Spectrum Europe BV, The Netherlands) to remove 
salts, lyophilized to obtain a white fluffy pure PA. Circular dichroism 
( D) was measured with Chirascan circular dichroism spectrometer 
(Applied Photophysic Ltd, UK) using quartz cell with 1 mm path 
length and the following parameters: data pitch—0.5 nm, scanning 
mode—continuous, scanning speed—100 nm min−1, bandwith—2 nm 
and accumulation—5. All CD data were presented as ellipticity and 
recorded in millidegree (mdeg). CD spectra were obtained by signal 
integrating 3 scans, from 190 to 260 nm at speed of 50 nm min−1. Data 
were processed by a simple moving average and smoothing method. 
Electron paramagnetic resonance spectroscopy was recorded on a 
Bruker EMX EPR equipped with a standard cavity, operating at X-band 
frequency using standard Wilmad quartz tubes at −80 °C. Transmission 
electron microscopy was performed on etched carbon-coated copper 
grids (Agar Scientific Ltd, Stanstead, UK) using JEOL 1230 TEM fitted 
with Morada CCD camera. Samples were stained with aqueous 2% 
uranyl acetate solution.
Hydrogel Preparation and Characterizations: The requisite concentration 
(6 wt%) of HA-Tyr was prepared in PBS containing 3 unit mL−1 of HRP 
and allowed to fully dissolve overnight at 4 °C. This concentration of 
HA-Tyr was used in all the hydrogel preparations. Gelation of the HA-Tyr 
was triggered by adding aqueous solution of H2O2 (0.75 × 10−3 M) and 
gentle mixing with a pipette tip. In order to prepare HA-Tyr-GHK-Cu2+ 
hydrogels, aqueous solution of GHK-Cu2+ (2 wt%) with 0.4 mg mL−1 
CuSO4) prepared in H2O2 (aq) (0.75 × 10−3 M) was added to HA-Try/
HRP solution with a quick mixing. To synthesize HA-Tyr-Lap hydrogels, 
aqueous suspension of Lap (5 wt%) exfoliated with sodium salt of 
polyacrylic acid (≈5000 Da Mw, 0.6 wt%) was initially mixed with 
aqueous solution HA-Tyr/HRP followed by the addition of H2O2 (aq) 
(0.75 × 10−3 M). Similarly, HA-Tyr-Lap-GHK-Cu2+ hydrogels were prepared 
Figure 6. a) Calculated new bone area in the sinus treated with HA-Tyr, HA-Tyr-GHK-Cu2+, HA-Tyr-Lap and HA-Tyr-Lap-GHK-Cu2+ hydrogels compared 
with the group treated with nothing (negative control) and those treated with Bio-Oss (positive control) at 6 and 12 weeks (* indicates significant differ-
ences, p < 0.001). Hematoxylin and eosin staining shows local histological image of the group treated with the multicomponent HA-Tyr-Lap-GHK-Cu2+ 
hydrogels at 12 weeks postoperation. b) Histological image showing osteocytes in the trabecular bone (red arrows) and osteoblasts on the surface 
of the new trabecular bones (yellow arrows) in the group treated with HA-Tyr-Lap-GHK-Cu2+ hydrogels. c) The blue arrows and yellow circles indicate 
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by adding aqueous solution of GHK-Cu2+/H2O2 to HA-Tyr/HRP/Lap 
mixture and mixed with a pipette tip.
Molecular Characterization of Coassembly: IR spectra were recorded 
on a PerkinElmer ATR-FTIR spectrometer in the range of 4000–400 cm−1 
at 2 cm−1 resolution. Fluorescence spectroscopy was carried out on a 
Hitachi F4500 spectrophotometer. Both excitation and emission slit 
width was 10.0 nm, scan speed was set to 200 nm min−1.
Unconfined Compression and Stress Relaxation Testing: Elastic moduli 
Eo and stress relaxation properties of the hydrogels were measured 
from the compression tests of the hydrogels with an Instron 560 
(Instron, Norwood, MA) using 10 N load cell to a compressive strain 
of 30% and a deformation rate of 1 mm s−1. The cylindrical hydrogels 
(diameter = height = 5 mm) were swollen in PBS for 6 h prior 
measurements and the testing was carried out inside a flat-bottom petri-
dish filled with PBS. Prior to the tests, an initial compressive contact of 
0.01 N was applied to ensure a complete contact between the hydrogels 
and the petri-dish. No bulging of the side faces of the hydrogels was 
observed. The slope of the stress versus strain curve gives Eo. After the 
compression test, the strain was held constant for 5 min, while the load 
was recorded as a function of time. In order to calculate the stress, the 
force was divided by the area of the hydrogels in the undeformed state. 
Tests were carried out three times to ensure reproducibility.
Swelling Properties and Enzymatic Digestion of Hydrogels: In order to 
determine the swelling properties of the hydrogels, the wet hydrogels 
were first freeze-dried to a constant initial weight (Wi). The dried 
xerogels were then incubated in PBS at 37 °C. The wet weights (Wt) 
of the hydrogels were measured at various time intervals during 
incubation until there was no noticeable increase in the weight the wet 
hydrogels. The percentage swelling of the hydrogels was calculated 
using the following equation (Wt  − Wi)/Wi  × 100). Degradation rate of 
the hydrogels was characterized by incubating the cylindrical hydrogels 
in PBS (pH = 7.2) for 24 h and then treated with hyaluronidases 
(20 unit mL−1). The remaining weight of the hydrogels was measured up 
to 50 h after enzymatic treatment. The weight loss was computed using 
equation (Wf  − Wi)/Wi  × 100, where Wi and Wf represent initial and 
final hydrogel weights, respectively.
Characterization of Microstructures: Microstructure of the hydrogels 
was observed using SEM. The hydrogels were frozen by liquid nitrogen 
and lyophilized to obtain dried samples. The dried gels were then 
sputter-coated with gold (10 nm thick) for 60 s. SEM micrographs 
of the dried xerogels were acquired on Inspect F50 (FEI Comp, the 
Netherlands). EDX spectroscopy was also used to analyze the dried 
gels coated with carbon to obtain elemental compositions of the dried 
xerogels.
In Vitro Experiments: Live/Dead assay—Live/dead assay was 
performed using a Live/Dead Cytotoxicity Kit (Thermo Fisher Scientific, 
UK) hMSCs (5000 cells mL−1) (Thermo Fisher Scientific, UK) seeded 
on various hydrogels at day 1, 3, and 7. Imaging was performed on an 
inverted confocal laser scanning microscope (CLSM, Leica, Germany). 
Proliferation—Cell proliferation was assessed by seeding 5000 hMSCs 
on various hydrogels. The cell seeded hydrogels were seeded incubated 
at 37 °C under 5% CO2 condition. Cell proliferation was quantitatively 
measured at various time points (day 1, 4, and 7) using PrestoBlue 
reagent (PrestoBlue Cell Viability Reagent, Thermo Fisher Scientific, 
UK). Briefly, the spent media was removed from each well and the 
cells were incubated with PrestoBlue reagent solution (100 µL). The 
cells were incubated for 1 h at 37 °C, away from light. Florescence 
measurements were carried out with using excitation wavelength of 
560 nm and an emission wavelength of 590 nm. Differentiation—Cell 
differentiation was assessed by seeding 20 000 hMSCs (passage 10) 
on various hydrogels with and without osteogenic media. Experiments 
were setup in 4 triplicates. With osteogenic media, cells were first 
cultured with basal media and replaced with osteogenic media after 
1 d. After each time point, cells were fixed using 4% formaldehyde for 
10 min and washed thrice with sterile dH2O. Cells were incubated with 
100 µL of SIGMAFAST BCIP/NBT reagent (Sigma, UK). ALP activity 
was spectroscopically quantified after days 4, 9, and 14 by measuring 
absorbance at 650 nm. Angiogenesis—hUVECs (5000) were seeded 
on various hydrogels. Cell-seeded hydrogels were incubated with 
supplemented endothelial cells growth media for 1 and 5 d. Cells were 
stained with calcein AM (2 × 10−3 M) and optical images were acquired 
on CLSM (Leica, Germany).
In Vivo Maxillary Sinus Floor Reconstruction Procedure: 30 healthy 
adult New Zealand rabbits were randomly divided into two study 
groups (control and experimental groups) for observation at week 6 and 
week 12. General anesthesia was performed through injection of 3% 
sodium pentobarbital via the marginal ear vein (1 mL kg−1). After the 
disappearance of eyelash reflex, the hair in the surgery region was shaved 
and the region was sterilized by 1% Iodine volts. A 2.5 cm incision 
on the nasal skin along the midline was made and the periosteum 
was stripped to expose the nasal bone and nasoincisal suture line. 
Two round windows at each side of the midline were prepared using 
bone drill. The windows were 5 mm in diameter and located ≈20 mm 
anterior to the nasofrontal suture line and 10 mm lateral to the midline. 
During the osteotomy, sterile saline solution was injected to the drill for 
continuous cooling and the sinus membrane was carefully protected. 
The mucosa and periosteum were gently elevated with a periosteum 
elevator and 50 µL gel was prepared in situ within the space upon 
the surface of the bone. In the experimental groups, four types of gel, 
as subgroups, including HA-Tyr, HA-Tyr-GHK-Cu2+, HA-Tyr-Lap, and 
HA-Tyr- Lap-GHK-Cu2+ was formed within the space. The space in the 
positive control group was filled with equal volume of Bio-oss and the 
space in blank control group was empty. The periosteum and skin were 
then sutured. Each group consisted of five animals.
Histological and Histomorphomeric Analysis: The animals were 
euthanized 6 and 12 weeks postsurgery by injecting sodium pentobarbital 
via the marginal ear vein (100 mg kg−1), and the sinuses were retrieved 
in blocks. The specimens were immediately fixed with paraformaldehyde 
(4%) for 48 h and demineralized by soaking them in 15% disodium 
ethylene diamine tetraacetate for 2 months and then washed in tap 
water for 15 min. All the specimens were trimmed and put into 70%, 
80%, 90%, 95%, 100% ethanol step by step for gradually dehydrate, 
and finally embedded in paraffin. Longitudinal histological HE slices of 
4 µm thickness were obtained to visualize the entire sinus. The sections 
were observed and digitally captured with a microscopic imaging system 
composed of a microscope (BX51, Olympus, Japan) and an image 
processing software, Cell Sens (Olympus, Japan). For the calculation 
of new bone area, Photoshop (Adobe Inc.) was first used to draw the 
outline of the new bone and ImageJ Fiji (developed by the National 
Institutes of Health and the Laboratory for Optical and Computational 
Instrumentation) was then used to calculate the new bone areas. Five 
slices were analyzed for each group. Fresh tissue blocks containing main 
organs including heart, liver, spleen, lung, and kidney were obtained and 
fixed with 4% paraformaldehyde to prepare HE stained slices analysis.
Statistical Analysis: Statistical comparisons between groups treated 
with various hydrogels, blank (negative control), and Bio-oss (positive 
control group) were performed using 2-way ANOVA followed by 
Bonferroni tests if significant differences were observed using Graph 
Prism software (San Diego). Tukey’s multiple comparison test was used 
for the cell proliferation and differentiation.
Supporting Information
Supporting Information is available from the Wiley Online Library or 
from the author.
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